Want to see HK:0401 full AI Analyst Report?
Wanjia Group Holdings Ltd. (0401) AI Stock Analysis
Wanjia Group Holdings Ltd.
(HKEX:0401)
The score is held down primarily by inconsistent profitability and a sharp deterioration in cash flow in 2026, which outweigh the benefit of a relatively conservative leverage profile. Technical indicators also suggest weak momentum (negative MACD and price below longer-term averages). Valuation is not supportive given the negative P/E tied to ongoing losses.
Wanjia Group Holdings Ltd. (0401) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 123.02M
- Dividend Yield
- ―
- Average Volume (3M)
- 1.13M
- Price to Earnings (P/E)
- -5.7
- Beta (1Y)
- 0.24
- Revenue Growth
- 2.28%
- EPS Growth
- -83.16%
- Country
- Hong Kong
- Employees
- 183
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Distribution
Wanjia Group Holdings Ltd. Business Overview & Revenue Model
Company Description
Wanjia Group Holdings Limited operates as an investment holding company, primarily engaged in the wholesale and distribution of pharmaceutical products across mainland China and Hong Kong. The firm also offers hemodialysis treatment and associated co...
Wanjia Group Holdings Ltd. Financial Statement Overview
Summary
Financial results are pressured by weak earnings quality: profitability has been inconsistent with losses in most years and margin deterioration in 2026 versus 2025. Cash flow adds risk as operating and free cash flow turned negative in 2026 after being positive in 2023–2025. Offsetting this, the balance sheet appears relatively stable with low debt-to-equity and higher equity in 2026, but repeated losses and negative ROE remain a key concern.
Income Statement
34NegativeBalance Sheet
62PositiveCash Flow
38Negative| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 203.54M | 165.38M | 161.69M | 181.09M | 173.70M | 154.82M |
| Gross Profit | 59.01M | 44.42M | 50.35M | 54.74M | 56.94M | 54.23M |
| EBITDA | 1.69M | -711.00K | 4.13M | -29.02M | 16.40M | -34.64M |
| Net Income | -13.16M | -9.86M | -6.62M | -39.98M | 1.82M | -51.00M |
Balance Sheet | ||||||
| Total Assets | 132.58M | 132.58M | 106.82M | 117.10M | 173.45M | 191.82M |
| Cash, Cash Equivalents and Short-Term Investments | 33.03M | 33.03M | 24.08M | 18.23M | 9.88M | 5.77M |
| Total Debt | 12.21M | 12.21M | 11.72M | 15.60M | 25.17M | 24.49M |
| Total Liabilities | 47.31M | 47.31M | 38.19M | 41.91M | 53.22M | 63.72M |
| Stockholders Equity | 83.65M | 83.65M | 66.88M | 73.49M | 118.20M | 126.18M |
Cash Flow | ||||||
| Free Cash Flow | -3.40M | -9.02M | 9.92M | 5.89M | 5.47M | -4.86M |
| Operating Cash Flow | -2.29M | -7.52M | 10.65M | 9.30M | 9.38M | 2.12M |
| Investing Cash Flow | -360.50K | -1.50M | -697.00K | 674.00K | -3.84M | -6.93M |
| Financing Cash Flow | -11.11M | 17.54M | -3.71M | -1.04M | -802.00K | -14.97M |
Wanjia Group Holdings Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0401, the sentiment is Positive. The current price of 0.11 is above the 20-day moving average (MA) of 0.10, above the 50-day MA of 0.11, and below the 200-day MA of 0.12, indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 59.77 is Neutral, neither overbought nor oversold. The STOCH value of 59.27 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:0401.
Wanjia Group Holdings Ltd. Peers Comparison
Overall Rating
HK:219271Outperform
HK:109965Neutral
HK:228947Neutral- HK:040143Neutral
HK:067339Underperform
HK:193126Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| HK:2192 | 71Outperform | HKD 4.67B | 11.61 | 7.05% | 4.98% | 6.47% | 8.10% |
| HK:1099 | 65Neutral | HKD 50.52B | 6.09 | 8.33% | 4.88% | 2.78% | 7.71% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| HK:2289 | 47Neutral | HKD 592.92M | 10.81 | 7.70% | 6.26% | 14.25% | 0.83% |
| HK:0401 | 43Neutral | HKD 123.02M | -5.74 | -19.15% | ― | 2.28% | -83.16% |
| HK:0673 | 39Underperform | HKD 360.66M | -5.29 | -273.18% | ― | 5.52% | 56.54% |
| HK:1931 | 26Underperform | HKD 575.63M | -6.45 | -2.60% | ― | -2.55% | -145.60% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:0401 | Wanjia Group Holdings Ltd. | 0.11 | -0.01 | -4.39% | |
| HK:0673 | China Health Group | 0.26 | -0.36 | -58.06% | |
| HK:1099 | Sinopharm Group Co Class H | 16.19 | -2.17 | -11.84% | |
| HK:1931 | IVD Medical Holding Limited | 0.35 | -5.93 | -94.35% | |
| HK:2192 | Medlive Technology Co., Ltd. | 6.30 | -4.03 | -38.99% | |
| HK:2289 | Charmacy Pharmaceutical Co., Ltd. Class H | 5.49 | 0.38 | 7.46% |
Wanjia Group Holdings Ltd. Corporate Events
Wanjia Group Wins Unanimous Shareholder Backing at AGM
Wanjia Group Holdings Ltd. reported that all resolutions proposed at its annual general meeting on 11 September 2026 were approved by shareholders voting by poll, with Tricor Investor Services Limited acting as scrutineer. The meeting covered adoptio...
Wanjia Group Details Auditor Re-Appointment and Fee Under New HKEX Guidelines
Wanjia Group Holdings Limited has issued a supplemental announcement to its AGM circular detailing the proposed re-appointment of HLB Hodgson Impey Cheng Limited as its auditor in line with updated Hong Kong Stock Exchange disclosure guidelines. The...
Wanjia Group Calls 2026 AGM to Approve Accounts, Board Changes and Share Mandate
Wanjia Group Holdings Ltd., incorporated in the Cayman Islands and listed on the Hong Kong Stock Exchange, operates under a conventional listed-company governance structure with a board made up of executive, non-executive and independent non-executiv...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 09, 2026